CODY SHINAVIER: Open Payments
NPI 1952878092 · CLARKSTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$31,604 in 307 payments from 16 companies in 2025. Trend: 2023 $2,956 · 2024 $3,195 · 2025 $31,604
Honoraria: $17,600Speaker / faculty: $6,618Food & beverage: $5,296Travel & lodging: $2,011Education: $80
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 49 | $20,409 |
| Teva Pharmaceuticals USA, Inc. | 34 | $7,345 |
| Vanda Pharmaceuticals Inc. | 34 | $619 |
| Otsuka America Pharmaceutical, Inc. | 38 | $606 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 38 | $560 |
| Axsome Therapeutics, Inc. | 14 | $410 |
| Collegium Pharmaceutical, Inc. | 25 | $306 |
| Janssen Pharmaceuticals, Inc | 9 | $273 |
| Corium, LLC | 11 | $249 |
| E.R. Squibb & Sons, L.L.C. | 21 | $248 |
Products named: Qelbree, UZEDY, FANAPT, CAPLYTA, Auvelity, ABILIFY MAINTENA, REXULTI, Jornay PM.
Industry payments across MI — which companies pay providers there.
